Story perspectives

Global Vaccination Efforts Thrive Amid Funding Cuts

12/23/2025

28 2

Summary

Story summary

Despite United States and United Kingdom funding cuts, progress remains.
Gavi, the Vaccine Alliance's HPV vaccination program has protected 86 million girls against cervical cancer.
Botswana and Rwanda reached 95% measles and rubella vaccination, contributing to an 88% drop in deaths since 2000.
Gilead Sciences, Inc. will provide Lenacapavir at no profit for two million people in sub-Saharan Africa.
Malaria and tuberculosis treatments show promise in trials.

1 of 1

Story summary

Despite United States and United Kingdom funding cuts, progress remains.
Gavi, the Vaccine Alliance's HPV vaccination program has protected 86 million girls against cervical cancer.
Botswana and Rwanda reached 95% measles and rubella vaccination, contributing to an 88% drop in deaths since 2000.
Gilead Sciences, Inc. will provide Lenacapavir at no profit for two million people in sub-Saharan Africa.
Malaria and tuberculosis treatments show promise in trials.